Dr. Reddy's Laboratories Limited (RDY)
NYSE: RDY · Real-Time Price · USD
13.30
-0.06 (-0.45%)
Jun 12, 2026, 4:00 PM EDT - Market closed
Dr. Reddy's Laboratories Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 335,933 | 325,535 | 279,164 | 245,879 | 214,391 | |
Revenue Growth (YoY) | 3.19% | 16.61% | 13.54% | 14.69% | 13.00% |
Cost of Revenue | 158,669 | 135,107 | 115,557 | 106,536 | 100,551 |
Gross Profit | 177,264 | 190,428 | 163,607 | 139,343 | 113,840 |
Selling, General & Admin | 106,763 | 93,870 | 77,201 | 68,026 | 62,081 |
Research & Development | 24,058 | 27,380 | 22,873 | 19,381 | 17,482 |
Other Operating Expenses | 11,146 | 6,051 | 4,202 | 6,606 | 10,323 |
Total Operating Expenses | 141,967 | 127,301 | 104,276 | 94,013 | 89,886 |
Operating Income | 35,297 | 63,127 | 59,331 | 45,330 | 23,954 |
Interest Income | 7,870 | 7,553 | 5,705 | 4,281 | 3,077 |
Interest Expense | -3,738 | -2,829 | -1,711 | -1,428 | -958 |
Other Non-Operating Income (Expense) | 4,266 | 4,941 | 4,141 | 3,223 | 2,822 |
Total Non-Operating Income (Expense) | 8,398 | 9,665 | 8,135 | 6,076 | 4,941 |
Pretax Income | 43,695 | 72,792 | 67,466 | 60,367 | 32,298 |
Provision for Income Taxes | 12,351 | 19,539 | 16,186 | 15,300 | 8,730 |
Net Income | 42,466 | 57,245 | 55,684 | 45,067 | 23,568 |
Minority Interest in Earnings | -384 | 701 | - | - | - |
Net Income to Common | 42,850 | 56,544 | 55,684 | 45,067 | 23,568 |
Net Income Growth | -24.22% | 1.54% | 23.56% | 91.22% | 36.72% |
Shares Outstanding (Basic) | 832 | 833 | 832 | 830 | 829 |
Shares Outstanding (Diluted) | 833 | 834 | 834 | 832 | 832 |
Shares Change (YoY) | -0.10% | 0.08% | 0.19% | 0.03% | 0.01% |
EPS (Basic) | 51.48 | 67.88 | 66.93 | 54.28 | 28.42 |
EPS (Diluted) | 51.42 | 67.78 | 66.80 | 54.17 | 28.34 |
EPS Growth | -24.14% | 1.47% | 23.32% | 91.16% | 36.70% |
Free Cash Flow | 33,429 | 18,924 | 29,030 | 47,552 | 13,448 |
Free Cash Flow Growth | 76.65% | -34.81% | -38.95% | 253.60% | -48.20% |
Free Cash Flow Per Share | 40.11 | 22.69 | 34.83 | 57.16 | 16.17 |
Dividends Per Share | 8.000 | 8.000 | 8.000 | 8.000 | 6.000 |
Dividend Growth | - | - | - | 33.33% | 20.00% |
Gross Margin | 52.77% | 58.50% | 58.61% | 56.67% | 53.10% |
Operating Margin | 10.51% | 19.39% | 21.25% | 18.44% | 11.17% |
Profit Margin | 12.64% | 17.58% | 19.95% | 18.33% | 10.99% |
FCF Margin | 9.95% | 5.81% | 10.40% | 19.34% | 6.27% |
EBITDA | 55,902 | 80,185 | 74,172 | 57,966 | 35,778 |
EBITDA Margin | 16.64% | 24.63% | 26.57% | 23.57% | 16.69% |
EBIT | 35,297 | 63,127 | 59,331 | 45,330 | 23,954 |
EBIT Margin | 10.51% | 19.39% | 21.25% | 18.44% | 11.17% |
Effective Tax Rate | 28.27% | 26.84% | 23.99% | 25.35% | 27.03% |